Sarah Schlesinger - Apr 13, 2022 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Role
Director
Signature
/s/ Todd R. Patrick, attorney-in-fact
Stock symbol
ARMP
Transactions as of
Apr 13, 2022
Transactions value $
$0
Form type
4
Date filed
4/15/2022, 03:54 PM
Previous filing
Jun 9, 2021
Next filing
Apr 27, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARMP Stock Options (Right to Buy) Award $0 +33K $0.00 33K Apr 13, 2022 Common Stock 33K $5.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each of the first and second annual anniversaries of the date of grant.